Dr. Dervishogullari contributes to LBG’s efforts in managing the successful planning and delivery of government and commercial programs. She leverages her technical expertise and understanding of the government requirements to help her clients navigate, secure, and manage non-dilutive funding across multiple funding agencies. Her project management experience includes development of vaccines, medical countermeasure therapeutics, and diagnostics. She has also assisted her clients with preparation of regulatory submissions and authored technical aspects of pre-INDs and INDs.
Dr. Dervishogullari completed her training in bioelectrochemistry under the mentorship of Dr. David Cliffel, whose research focuses on electrochemical sensor development for organ-on-a-chip systems and the utilization of photoactive plant proteins in solar energy conversion. She is knowledgeable in a wide variety of analytical and biophysical methods, including monitoring of small molecule target engagement in living cells.
During her training, Dr. Dervishogullari also served as an intern at Vanderbilt University’s technology transfer and commercialization office, where she worked alongside licensing officers and principal investigators to determine the patentability of new pharmaceutical and medical device technologies and assisted in marketing initiatives. Throughout her academic career, Dr. Dervishogullari has authored several peer-reviewed scientific journal publications and presented her work at various national and international conferences. She has extensive experience in communicating science into formats that appeal to both scientific and lay audiences.
Dr. Dervishogullari received her Ph.D. in Chemistry from Vanderbilt University and her B.S. in Chemistry from Grinnell College.
